[PRESS RELEASE] – EDMONTON, Alberta, June 26, 2025 – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, is pleased to have recently expanded the eligibility of its medical compassionate pricing program in Canada.
As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from CA$40,000 to CA$60,000 for Aurora patients through AuroraMedical.com.
"As over half of the country's adult population fits within this income threshold, our compassionate pricing program represents the most accessible, inclusive pricing plan to access medical cannabis in Canada," said Geoff Hoover, senior vice president of Canadian Commercial at Aurora. "We're committed to breaking down barriers to access high-quality medical cannabis, and this change empowers more patients to explore different treatment options at pricing they can afford."
The changes to the compassionate pricing program are available alongside new medical cannabis products, including:
- Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg)
- Daily Special | Sativa J's - THC Pre-Rolls, Sativa (7 x 0.3g)
- WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg)
In addition to the compassionate pricing program, Aurora offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team for further support.
